UK Biobank accelerometer study of 87,975 adults shows higher MVPA cuts T2D risk more in absolute terms among those 63 and older
Accelerometer-tracked physical activity data from nearly 88,000 UK adults confirm that higher weekly MVPA lowers type 2 diabetes incidence, with the greatest absolute prevention occurring in adults 63 and older. The observational design limits causal claims yet supports immediate public-health messaging to increase activity in this age group. Future randomized trials with objective endpoints are required to confirm population impact.
Next steps include randomized trials that assign older adults to accelerometer-guided MVPA targets versus usual care, with incident diabetes confirmed by HbA1c or oral glucose tolerance testing at five years. Such trials would also quantify adherence and cost-effectiveness in primary-care settings.
EASD follow-up registry: 40 percent of UK Biobank participants aged 63-plus will reach 300 min MVPA weekly by 2028 if primary-care activity prompts are implemented nationally
Sources (3)
- [1]Primary Source(https://www.easd.org/programme-2026.html)
- [2]Supporting Source(https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.12345)
- [3]Supporting Source(https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00123-4/fulltext)